Assessing and achieving readiness to initiate HIV medication

Patient Educ Couns. 2006 Jul;62(1):21-30. doi: 10.1016/j.pec.2005.09.014.

Abstract

Objective: To summarise published HIV-specific research on readiness theories, factors influencing readiness, instruments to measure readiness and interventions to increase readiness for treatment.

Methods: Medline and PsychInfo were searched until August 2004.

Results: Two HIV-specific readiness theories were identified. Fear of side effects, emotions emerging from the diagnosis and lack of trust in the physician were some barriers to overcome in order to reach readiness. Of the three measurement instruments found, the index of readiness showed the most promise. Multi-step intervention programs to increase readiness for HIV treatment had been investigated.

Conclusion: Readiness instruments may be useful tools in clinical practice but the predictive validity of the instruments needs to be further established in the HIV-infected population.

Practice implications: Readiness instruments and practice placebo trials may serve as complements to routine care, since health care providers currently have no better than chance probability in identifying those patients who are ready to adhere.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adaptation, Psychological
  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / therapeutic use*
  • Communication
  • Emotions
  • Fear
  • HIV Infections* / drug therapy
  • HIV Infections* / psychology
  • Health Behavior
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Needs Assessment / organization & administration*
  • Negativism
  • Nursing Assessment / methods*
  • Nursing Assessment / standards
  • Patient Compliance / psychology*
  • Patient Education as Topic
  • Physician-Patient Relations
  • Predictive Value of Tests
  • Psychological Theory
  • Qualitative Research
  • Reproducibility of Results
  • Research Design
  • Surveys and Questionnaires
  • Trust

Substances

  • Anti-HIV Agents